ABSTRACT Objectives Immune checkpoint inhibitors (ICIs) are one of the most promising
approaches toward advanced melanoma. Here, we aimed to perform a meta-analysis of …

Abstract Background Immune checkpoint inhibitors (ICIs) have entered the treatment
paradigm for unresectable advanced melanoma, but there is a lack of evidence regarding its …

Background: Immune checkpoint inhibitors (ICIs) are approved as cancer
immunotherapeutic agents for advanced malignant melanoma (MM) in recent years, and …

Background: This systematic review and meta-analysis aims to provide comparative and
quantitative data about immune checkpoint inhibitor (IMM) and targeted therapy (TAR) in this …

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current
approach to cancer treatment. Although the use of ICIs has become the standard of care for …

Background and objectives Rates of malignant melanoma are continuing to increase, and
until recently effective treatments were lacking. However, since 2011 three …

Immune checkpoint inhibitors (ICIs) have unprecedented effects on the treatment of
metastatic melanoma. However, little is known about the prognostic values of various …

Objectives We aimed to compare and rank the effects of 9 immune checkpoint inhibitor-
related therapies for treating advanced melanoma. Methods We searched Pubmed …

Introduction This systematic scoping review compares the toxicities experienced by patients
receiving immune checkpoint inhibitors (ICIs) or targeted therapy (TT) for stage III (resected …

Abstract Background Immune checkpoint inhibitors (ICIs) have advanced the therapeutic
landscape for malignant melanoma patients. However, they can cause permanent and …